Speaker: Seppo Ylä-Herttuala, M.D., Ph.D., a leader in cardiovascular gene therapy, runs a laboratory in both cardiovascular and malignant glioma gene therapy. He is a professor, A.I. Virtanan Institute for Molecular Science; Faculty of Health Sciences; Director of the Biocenter Kuopio; National Director EU EATRIS-ERIC infrastructure networ; and Director of the National Virus Vector Laboratory
 

REGISTER TO ATTEND THIS FREE EVENT (virtual or in person)
 

NextGen Precision Health Discovery Series monthly lectures are geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts.